These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8402675)

  • 1. Metallothionein: a protein conferring resistance in vitro to tumor necrosis factor.
    Leyshon-Sørland K; Mørkrid L; Rugstad HE
    Cancer Res; 1993 Oct; 53(20):4874-80. PubMed ID: 8402675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased resistance to chlorambucil in cultured cells with a high concentration of cytoplasmic metallothionein.
    Endresen L; Bakka A; Rugstad HE
    Cancer Res; 1983 Jun; 43(6):2918-26. PubMed ID: 6850603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of metallothionein confers resistance to the cytotoxic effect of TNF with cadmium in MCF-7 breast carcinoma cells.
    Sciavolino PJ; Lee TH; Vilcek J
    Lymphokine Cytokine Res; 1992 Oct; 11(5):265-70. PubMed ID: 1467367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallothionein localization and cisplatin resistance in human hormone-independent prostatic tumor cell lines.
    Kondo Y; Kuo SM; Watkins SC; Lazo JS
    Cancer Res; 1995 Feb; 55(3):474-7. PubMed ID: 7834610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallothionein expression and resistance to cisplatin in a human germ cell tumor cell line.
    Koropatnick J; Kloth DM; Kadhim S; Chin JL; Cherian MG
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1681-7. PubMed ID: 8531144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered cisplatin and cadmium resistance and cell survival in Chinese hamster ovary cells expressing mouse metallothionein.
    Koropatnick J; Pearson J
    Mol Pharmacol; 1993 Jul; 44(1):44-50. PubMed ID: 8341278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 beta-mediated metallothionein induction and cytoprotection against cadmium and cis-diamminedichloroplatinum.
    Kondo Y; Kuo SM; Lazo JS
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1313-8. PubMed ID: 7932184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothionein induction and deinduction in human prostatic carcinoma cells: relationship with resistance and sensitivity to adriamycin.
    Webber MM; Rehman SM; James GT
    Cancer Res; 1988 Aug; 48(16):4503-8. PubMed ID: 3396002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between radiosensitivity and metallothionein content in clones from a mouse squamous cell carcinoma.
    Miura M; Sasaki T
    Radiat Res; 1990 Aug; 123(2):171-5. PubMed ID: 2389003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rottlerin stimulates metallothionein gene expression but inhibits metal transport in Chinese hamster ovary cells.
    Chen JH; Huang CH; Lin LY
    Toxicol Appl Pharmacol; 2001 Dec; 177(3):256-63. PubMed ID: 11749125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of in vitro resistance to 4'-epidoxorubicin and cis-dichlorodiammineplatinum in hepatoma cells.
    Hall KS; Endresen L; Huitfeldt HS; Rugstad HE
    Anticancer Res; 1991; 11(2):817-23. PubMed ID: 1676581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonprotective effects of extracellular metallothionein.
    Borghesi LA; Lynes MA
    Toxicol Appl Pharmacol; 1996 Jul; 139(1):6-14. PubMed ID: 8685909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the cytotoxic effect of prednimustine in cultured cells with high or low levels of metallothionein.
    Endresen L
    Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):49-57. PubMed ID: 6702467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of metallothionein expression in human and murine hepatocellular tumors: association with the tumor-necrotizing and antineoplastic effects of cadmium in mice.
    Waalkes MP; Diwan BA; Rehm S; Ward JM; Moussa M; Cherian MG; Goyer RA
    J Pharmacol Exp Ther; 1996 May; 277(2):1026-33. PubMed ID: 8627513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor expression and function control cytotoxic responsiveness to tumor necrosis factor in ME-180 squamous carcinoma cells.
    Donato NJ; Yan DH; Hung MC; Rosenblum MG
    Cell Growth Differ; 1993 May; 4(5):411-9. PubMed ID: 8518234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metallothionein as a resistance factor for antitumor drugs].
    Imura N; Naganuma A; Satoh M
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):599-604. PubMed ID: 2705789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of nuclear factor-kappaB activation confers sensitivity to tumor necrosis factor-alpha by impairment of cell cycle progression in human glioma cells.
    Otsuka G; Nagaya T; Saito K; Mizuno M; Yoshida J; Seo H
    Cancer Res; 1999 Sep; 59(17):4446-52. PubMed ID: 10485496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of cytokines in the hepatic expression of metallothionein by ursolic acid.
    Jeong HG; Kim HG; Hwang YP
    Toxicol Lett; 2005 Mar; 155(3):369-76. PubMed ID: 15649620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
    Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat hepatocytes with elevated metallothionein expression are resistant to N-methyl-N'-nitro-N-nitrosoguanidine cytotoxicity.
    Moffatt P; Plaa GL; Denizeau F
    Toxicol Appl Pharmacol; 1996 Jan; 136(1):200-7. PubMed ID: 8560476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.